BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
Wei Yang, Yingying Liu, Ruoling Gao, Zenghe Xiu, Ting Sun. Knockdown of cZNF292 suppressed hypoxic human hepatoma SMMC7721 cell proliferation, vasculogenic mimicry, and radioresistanceCellular Signalling 2019; 60: 122 doi: 10.1016/j.cellsig.2019.04.011
Michelle R. Ju, Adam C. Yopp. Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experienceAnnals of Gastroenterological Surgery 2020;  doi: 10.1002/ags3.12316
Luke V. Selby, Aslam Ejaz, Stacy A. Brethauer, Timothy M. Pawlik. Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgeryExpert Opinion on Investigational Drugs 2020; 29(2): 107 doi: 10.1080/13543784.2020.1721457
Xi-Zhen Chen, Wei Kevin Zhang, He-Bin Tang, Xiao-Jun Li, Gui-Hua Tian, Hong-Cai Shang, Yu-Sang Li. The Ethanol Supernatant Extracts of Liushenwan Could Alleviate Nanodiethylnitrosamine-Induced Liver Cancer in MiceCanadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/6934809
Eric vanSonnenberg, Peter R. Mueller. Complex Therapeutic Strategies for Hepatocellular Carcinoma: Expanding CriteriaRadiology 2019; 293(3): 716 doi: 10.1148/radiol.2019192151